These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3756701)

  • 21. [Vaccination plan for children. Recommendation of the German Society for Social Pediatrics and the German Green Cross].
    Med Klin; 1973 Dec; 68(50):1637-8. PubMed ID: 4782872
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimizing pediatric clinical care and advocacy in an online era: report of the Canadian Paediatric Society Infectious Diseases and Immunization Committee.
    Dollin J
    Can Fam Physician; 2014 Jul; 60(7):625-30. PubMed ID: 25022634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The societal value of universal childhood vaccination.
    Chabot I; Goetghebeur MM; Grégoire JP
    Vaccine; 2004 May; 22(15-16):1992-2005. PubMed ID: 15121312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creating a sustainable immunization system in Canada--the case for a vaccine-related injury compensation scheme.
    Kutlesa NJ
    Health Law J; 2004; 12():201-42. PubMed ID: 16539082
    [No Abstract]   [Full Text] [Related]  

  • 25. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations.
    McInerny TK; Cull WL; Yudkowsky BK
    Pediatrics; 2005 Apr; 115(4):833-8. PubMed ID: 15805352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for a vaccine injury compensation program for Canada.
    Wilson K; Keelan J
    Can J Public Health; 2012; 103(2):122-4. PubMed ID: 22530534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DTP vaccine related injury: an examination of proposed vaccine injury compensation legislation.
    Murray PC
    J Contemp Health Law Policy; 1987; 3():233-51. PubMed ID: 11645601
    [No Abstract]   [Full Text] [Related]  

  • 28. Should the vaccine injury compensation program be expanded to cover adults?
    Lloyd-Puryear MA; Ball LK; Benor D
    Public Health Rep; 1998; 113(3):236-42. PubMed ID: 9633868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Law and medicine: medical defense in Canada. American Medical Association Office of the General Counsel.
    Bergen RP
    Int J Orthod; 1971 Sep; 9(3):245-7. PubMed ID: 5286525
    [No Abstract]   [Full Text] [Related]  

  • 30. A national compensation program for vaccine-related injuries.
    Karzon DT
    N Engl J Med; 1984 May; 310(20):1320-2. PubMed ID: 6717496
    [No Abstract]   [Full Text] [Related]  

  • 31. Ribavirin: indications for use in pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1986 Dec; 135(12):1351-2. PubMed ID: 3779570
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccine issue foremost in clinical medicine.
    Busch L
    Am Med News; 1985 Jan; 28(1):13. PubMed ID: 11653614
    [No Abstract]   [Full Text] [Related]  

  • 33. The Canadian Paediatric Society: its early years.
    Ebbs JH
    Can Med Assoc J; 1980 Dec; 123(12):1235-7. PubMed ID: 7006775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
    Pisano W
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 38. Alternatives to manufacturer liability for injuries caused by the Sabin-type oral polio vaccines.
    Spence FF
    William Mary Law Rev; 1987; 28(4):711-42. PubMed ID: 11658951
    [No Abstract]   [Full Text] [Related]  

  • 39. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999.
    Geier DA; Geier MR
    Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
    Scheifele D; Halperin S; Pelletier L; Talbot J
    Clin Infect Dis; 2000 Jul; 31(1):58-64. PubMed ID: 10913397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.